ACE2 and COVID-19: Glial cells express SARS-COV-2 receptors such as angiotensin converting enzyme 2 (ACE2) and cathepsin L (CTSL), which may be responsible for making glioma patients more susceptible to SARS-CoV-2 infection and at higher risk for severe COVID-19 [65, 66].